Markets swallow the post-Omicron outlook pill
Demand for oil is reflecting the view that markets will reopen faster, says NAB’s Rodrigo Catril. Pfizer’s morning-after COVID pill will help with that, but it won’t help with inflation concerns.
Demand for oil is reflecting the view that markets will reopen faster, says NAB’s Rodrigo Catril. Pfizer’s morning-after COVID pill will help with that, but it won’t help with inflation concerns.
The Times says the government is struggling with what to do with a windfall tax if they had one. One option they reckon is to reduce the cost of energy. Which of course helps everyone, but richer higher energy users would be the biggest beneficiary ...
No bounce in equity indices today, says NAB’s Taylor Nugent. It’s all down to growing concerns about a US economic slowdown. Like Cisco’s profit downgrade, for example. Plus the lowdown on yesterday’s Aussie employment numbers. https://t.co/aGBhCkChFv